New Cancer Drug Approved

Yet, researchers are working quite hard. And billions of dollars are being spent.

Quite recently, the FDA approved a new and VERY expensive cancer drug. As CNN reports:

“Vitrakvi is the first medication developed specifically to target tumors based on gene mutations, not their location in the body.”

Read more

Apple and Stanford Partner on Smart Watch Study

This important study is huge.

As Nicky Lineaweaver reports for Business Insider:

“Apple and Stanford Medicine enrolled more than 400,000 participants in the Apple Heart Study since its launch in November of 2017 — making it the largest study on atrial fibrillation (AFib) ever conducted.

Read more